Skip to content
Learn More

Media & Events

CDMO makes an AI and drug discovery play in latest, small-time acquisition

September 22, 2022

The CDMO outfit iBio has netted a deal that sees it gain access to an AI-based platform as well as new therapeutic candidates as it looks to dive further into drug discovery.

Read More
Top